Letters
Antidepressant use and FDA warnings
Impossible to draw meaningful conclusions from study of changes in antidepressant use after FDA warnings
BMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g5643 (Published 09 October 2014) Cite this as: BMJ 2014;349:g5643- John M Nardo, retired psychiatrist, Emory University1
- 13720 Grandview Road, Jasper, GA 30143, USA
- jnardo{at}ellijay.com
In 2010, Patrick and colleagues queried two databases with high rates of external injury coding (E coding) completeness to find a proxy for absent E codes. They chose “a diagnosis of poisoning, toxic effects, open wound to elbow, wrist, or forearm, or asphyxiation; plus a diagnosis of depression, mania, personality disorder, psychotic disorder, or adjustment reaction” on the basis of sensitivity, specificity, and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.